| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural constituent of skin epidermis | 6.87e-05 | 43 | 37 | 3 | GO:0030280 | |
| GeneOntologyBiologicalProcess | keratinization | 6.11e-07 | 87 | 39 | 5 | GO:0031424 | |
| GeneOntologyBiologicalProcess | keratinocyte differentiation | 2.74e-05 | 189 | 39 | 5 | GO:0030216 | |
| GeneOntologyBiologicalProcess | skin development | 6.62e-05 | 373 | 39 | 6 | GO:0043588 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | 9.22e-05 | 1269 | 39 | 10 | GO:0009887 | |
| GeneOntologyBiologicalProcess | epidermal cell differentiation | 1.87e-04 | 284 | 39 | 5 | GO:0009913 | |
| GeneOntologyBiologicalProcess | ventral spinal cord interneuron fate commitment | 2.27e-04 | 12 | 39 | 2 | GO:0060579 | |
| GeneOntologyBiologicalProcess | cell fate commitment involved in pattern specification | 2.27e-04 | 12 | 39 | 2 | GO:0060581 | |
| GeneOntologyBiologicalProcess | ventral spinal cord interneuron differentiation | 3.12e-04 | 14 | 39 | 2 | GO:0021514 | |
| GeneOntologyCellularComponent | cornified envelope | 9.08e-06 | 69 | 40 | 4 | GO:0001533 | |
| GeneOntologyCellularComponent | nascent polypeptide-associated complex | 3.56e-05 | 5 | 40 | 2 | GO:0005854 | |
| GeneOntologyCellularComponent | guanyl-nucleotide exchange factor complex | 9.59e-04 | 24 | 40 | 2 | GO:0032045 | |
| Domain | SPRR2 | 1.95e-10 | 6 | 37 | 4 | IPR029142 | |
| Domain | SPRR2 | 1.95e-10 | 6 | 37 | 4 | PF14820 | |
| Domain | SPRR/LCE | 2.58e-07 | 28 | 37 | 4 | IPR026075 | |
| Domain | EGD2/NACA | 1.14e-05 | 3 | 37 | 2 | IPR016641 | |
| Domain | NAC | 3.80e-05 | 5 | 37 | 2 | SM01407 | |
| Domain | NAC | 5.70e-05 | 6 | 37 | 2 | PF01849 | |
| Domain | Nas_poly-pep-assoc_cplx_dom | 5.70e-05 | 6 | 37 | 2 | IPR002715 | |
| Domain | NAC_AB | 5.70e-05 | 6 | 37 | 2 | PS51151 | |
| Domain | VWC | 1.40e-03 | 28 | 37 | 2 | PF00093 | |
| Domain | Laminin_EGF | 2.18e-03 | 35 | 37 | 2 | PF00053 | |
| Domain | EGF_Lam | 2.18e-03 | 35 | 37 | 2 | SM00180 | |
| Domain | VWFC_1 | 2.31e-03 | 36 | 37 | 2 | PS01208 | |
| Domain | LAM_G_DOMAIN | 2.57e-03 | 38 | 37 | 2 | PS50025 | |
| Domain | VWC | 2.57e-03 | 38 | 37 | 2 | SM00214 | |
| Domain | Laminin_EGF | 2.57e-03 | 38 | 37 | 2 | IPR002049 | |
| Domain | VWFC_2 | 2.57e-03 | 38 | 37 | 2 | PS50184 | |
| Domain | VWF_dom | 3.13e-03 | 42 | 37 | 2 | IPR001007 | |
| Domain | LamG | 3.43e-03 | 44 | 37 | 2 | SM00282 | |
| Domain | fn3 | 4.01e-03 | 162 | 37 | 3 | PF00041 | |
| Domain | FN3 | 5.80e-03 | 185 | 37 | 3 | SM00060 | |
| Domain | Laminin_G | 5.89e-03 | 58 | 37 | 2 | IPR001791 | |
| Domain | FN3 | 7.09e-03 | 199 | 37 | 3 | PS50853 | |
| Domain | RRM_1 | 8.01e-03 | 208 | 37 | 3 | PF00076 | |
| Domain | FN3_dom | 8.11e-03 | 209 | 37 | 3 | IPR003961 | |
| Domain | RRM | 8.99e-03 | 217 | 37 | 3 | SM00360 | |
| Domain | RRM_dom | 1.02e-02 | 227 | 37 | 3 | IPR000504 | |
| Domain | RRM | 1.05e-02 | 230 | 37 | 3 | PS50102 | |
| Domain | EGF_3 | 1.12e-02 | 235 | 37 | 3 | PS50026 | |
| Domain | EGF | 1.12e-02 | 235 | 37 | 3 | SM00181 | |
| Domain | - | 1.23e-02 | 244 | 37 | 3 | 3.30.70.330 | |
| Domain | EGF-like_dom | 1.30e-02 | 249 | 37 | 3 | IPR000742 | |
| Domain | EGF_1 | 1.39e-02 | 255 | 37 | 3 | PS00022 | |
| Domain | Nucleotide-bd_a/b_plait | 1.43e-02 | 258 | 37 | 3 | IPR012677 | |
| Domain | EGF-like_CS | 1.48e-02 | 261 | 37 | 3 | IPR013032 | |
| Domain | - | 1.52e-02 | 95 | 37 | 2 | 2.60.120.200 | |
| Domain | EGF_2 | 1.54e-02 | 265 | 37 | 3 | PS01186 | |
| Pathway | REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE | 7.04e-06 | 129 | 30 | 5 | M27649 | |
| Pathway | REACTOME_KERATINIZATION | 8.59e-05 | 217 | 30 | 5 | M27640 | |
| Pubmed | Estrogen regulates the expression of the small proline-rich 2 gene family in the mouse uterus. | 1.05e-10 | 8 | 40 | 4 | 15232223 | |
| Pubmed | 1.88e-10 | 9 | 40 | 4 | 11279051 | ||
| Pubmed | 3.13e-10 | 10 | 40 | 4 | 8325635 | ||
| Pubmed | 7.37e-10 | 12 | 40 | 4 | 9888996 | ||
| Pubmed | 7.37e-10 | 12 | 40 | 4 | 18643845 | ||
| Pubmed | 1.41e-08 | 5 | 40 | 3 | 3133554 | ||
| Pubmed | 4.92e-08 | 7 | 40 | 3 | 31884525 | ||
| Pubmed | Mouse Sprr locus: a tandem array of coordinately regulated genes. | 7.86e-08 | 8 | 40 | 3 | 12584609 | |
| Pubmed | 7.86e-08 | 8 | 40 | 3 | 15574822 | ||
| Pubmed | 7.86e-08 | 8 | 40 | 3 | 11038185 | ||
| Pubmed | Ovarian development in mice requires the GATA4-FOG2 transcription complex. | 8.60e-08 | 36 | 40 | 4 | 18927154 | |
| Pubmed | The mineralocorticoid receptor plays a transient role in mouse skin development. | 4.00e-07 | 13 | 40 | 3 | 26268211 | |
| Pubmed | Novel markers of early ovarian pre-granulosa cells are expressed in an Sry-like pattern. | 5.08e-07 | 14 | 40 | 3 | 19301398 | |
| Pubmed | Amniotic fluid activates the nrf2/keap1 pathway to repair an epidermal barrier defect in utero. | 5.08e-07 | 14 | 40 | 3 | 23237955 | |
| Pubmed | 6.35e-07 | 15 | 40 | 3 | 20880987 | ||
| Pubmed | Subcellular localization of ATBF1 regulates MUC5AC transcription in gastric cancer. | 1.29e-06 | 2 | 40 | 2 | 17330845 | |
| Pubmed | 1.58e-06 | 20 | 40 | 3 | 21466799 | ||
| Pubmed | 2.14e-06 | 22 | 40 | 3 | 24899573 | ||
| Pubmed | 2.14e-06 | 22 | 40 | 3 | 16949565 | ||
| Pubmed | 3.18e-06 | 25 | 40 | 3 | 31410202 | ||
| Pubmed | 3.87e-06 | 3 | 40 | 2 | 9722562 | ||
| Pubmed | ZFP750 affects the cutaneous barrier through regulating lipid metabolism. | 6.19e-06 | 31 | 40 | 3 | 37115925 | |
| Pubmed | Expression and regulation of cornified envelope proteins in human corneal epithelium. | 7.73e-06 | 4 | 40 | 2 | 16639001 | |
| Pubmed | Capturing genes encoding membrane and secreted proteins important for mouse development. | 1.29e-05 | 5 | 40 | 2 | 7604039 | |
| Pubmed | 1.35e-05 | 40 | 40 | 3 | 19864314 | ||
| Pubmed | 4.61e-05 | 60 | 40 | 3 | 31220272 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | 5.01e-05 | 351 | 40 | 5 | 38297188 | |
| Pubmed | 5.08e-05 | 62 | 40 | 3 | 26644517 | ||
| Pubmed | Meta-analysis identifies six new susceptibility loci for atrial fibrillation. | 8.45e-05 | 12 | 40 | 2 | 22544366 | |
| Pubmed | 8.45e-05 | 12 | 40 | 2 | 24475213 | ||
| Pubmed | 1.53e-04 | 16 | 40 | 2 | 21266775 | ||
| Pubmed | Sidekick 2 directs formation of a retinal circuit that detects differential motion. | 3.21e-04 | 23 | 40 | 2 | 26287463 | |
| Pubmed | Notch signaling in stomach epithelial stem cell homeostasis. | 5.13e-04 | 29 | 40 | 2 | 21402740 | |
| Pubmed | Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci. | 5.13e-04 | 29 | 40 | 2 | 22190364 | |
| Pubmed | 5.50e-04 | 30 | 40 | 2 | 20301299 | ||
| Pubmed | Functional analysis of secreted and transmembrane proteins critical to mouse development. | 5.87e-04 | 31 | 40 | 2 | 11431694 | |
| Pubmed | Transcriptome analysis of mouse and human sinoatrial node cells reveals a conserved genetic program. | 6.26e-04 | 32 | 40 | 2 | 30936179 | |
| Pubmed | Genetic variations in humans associated with differences in the course of hepatitis C. | 6.26e-04 | 32 | 40 | 2 | 15063762 | |
| Pubmed | Radial glia require PDGFD-PDGFRβ signalling in human but not mouse neocortex. | 7.07e-04 | 34 | 40 | 2 | 25391964 | |
| Pubmed | Telencephalic embryonic subtractive sequences: a unique collection of neurodevelopmental genes. | 9.11e-04 | 165 | 40 | 3 | 16107646 | |
| Pubmed | A neurogenomics approach to gene expression analysis in the developing brain. | 9.93e-04 | 170 | 40 | 3 | 15582152 | |
| Cytoband | 1q21-q22 | 4.32e-09 | 23 | 40 | 4 | 1q21-q22 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q21 | 2.63e-05 | 404 | 40 | 5 | chr1q21 | |
| GeneFamily | Small proline rich proteins | 1.29e-09 | 11 | 27 | 4 | 1353 | |
| GeneFamily | Fibronectin type III domain containing | 1.70e-03 | 160 | 27 | 3 | 555 | |
| GeneFamily | RNA binding motif containing | 3.83e-03 | 213 | 27 | 3 | 725 | |
| Coexpression | HUMMERICH_BENIGN_SKIN_TUMOR_UP | 3.69e-06 | 20 | 40 | 3 | MM491 | |
| Coexpression | HUMMERICH_MALIGNANT_SKIN_TUMOR_UP | 5.71e-06 | 23 | 40 | 3 | MM492 | |
| ToppCell | primary_visual_cortex-Non-neuronal-leptomeningeal_cell|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.82e-07 | 174 | 40 | 5 | 2891ab2fd05eb4bbd239d1a2865f21ef7f2df39e | |
| ToppCell | primary_visual_cortex-Non-neuronal-leptomeningeal_cell-VLMC|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.82e-07 | 174 | 40 | 5 | eade55f86ef1f7a5355ad65cec3aa6bfc5d3c62d | |
| ToppCell | primary_visual_cortex-Non-neuronal-leptomeningeal_cell-VLMC-VLMC_Osr1_Mc5r|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.24e-07 | 177 | 40 | 5 | 599cf7f5b774e197a1b43c98e4b9a8c1a618f38a | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.54e-07 | 179 | 40 | 5 | 2b5f8e109a67c7fc3ec2b83e8f1854160c99283a | |
| ToppCell | NS-critical-d_07-13-Epithelial-Squamous|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.24e-07 | 194 | 40 | 5 | 53a34843d529ef395deb27086f71f7049a087bab | |
| ToppCell | critical-Epithelial-Squamous|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 8.89e-07 | 197 | 40 | 5 | eccc80d6ab79c46b10108de1cff3abeacfc105cd | |
| ToppCell | Bronchial_Brush-Epithelial-Ciliated_2|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 5.96e-06 | 132 | 40 | 4 | 780a391924f776dc6fbe44ddcf4ae0583a1e2157 | |
| ToppCell | Bronchial_Brush-Epithelial-Ciliated_2|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 6.51e-06 | 135 | 40 | 4 | 366a417f9ef7c0d86e9f262d97bf788f478315ee | |
| ToppCell | Club_cells-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 9.12e-06 | 147 | 40 | 4 | 5a824c89e4d045af465d7333275f8191fb29b041 | |
| ToppCell | normal_Lung-Fibroblasts-Mesothelial_cells|Fibroblasts / Location, Cell class and cell subclass | 1.51e-05 | 167 | 40 | 4 | 892a2dc83ab5de5a1016402f8e95d2aabf651326 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-proliferative_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.58e-05 | 169 | 40 | 4 | a84490724a206c9bbb145f7ce08613f91d100ac4 | |
| ToppCell | frontal_cortex-Non-neuronal-leptomeningeal_cell|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.65e-05 | 171 | 40 | 4 | 2e43fb129ee9bdc3b31febc43c10f959bf0f4a7d | |
| ToppCell | TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Non-Papillary_Muscle_Invasive_Urothelial_Carcinoma-6|TCGA-Bladder / Sample_Type by Project: Shred V9 | 1.65e-05 | 171 | 40 | 4 | 0e78389f8f3d54570a6deb3dd307b865b46307e9 | |
| ToppCell | frontal_cortex-Non-neuronal-leptomeningeal_cell-VLMC|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.65e-05 | 171 | 40 | 4 | e219a1aa59a96e4bc3e2eacf985679174a51de41 | |
| ToppCell | AT1-AT2_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 1.69e-05 | 172 | 40 | 4 | 0be41df5d35d818deb7316ac21c9366eb4b7bfd1 | |
| ToppCell | TCGA-Head_and_Esophagus|World / Sample_Type by Project: Shred V9 | 1.69e-05 | 172 | 40 | 4 | eb18aa179db1818f408c38e442ecfed8582d7dbc | |
| ToppCell | PSB-critical-LOC-Epithelial-Squamous|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.16e-05 | 183 | 40 | 4 | 2cf798a2371c61322484ea16fdfae0acfa94f102 | |
| ToppCell | 21-Trachea-Mesenchymal-Airway_Smooth_Muscle|Trachea / Age, Tissue, Lineage and Cell class | 2.21e-05 | 184 | 40 | 4 | 86a96cd88e50eacad1f0badfbbf6dc626f41725e | |
| ToppCell | 3'-Child04-06-SmallIntestine-Endothelial-lymphatic_endothelial|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.30e-05 | 186 | 40 | 4 | eeacf59a9e6bf1c9fd59b6b13d35e8abae228cf0 | |
| ToppCell | TCGA-Skin-Primary_Tumor|TCGA-Skin / Sample_Type by Project: Shred V9 | 2.50e-05 | 190 | 40 | 4 | e2b26a03c6ab24d9b0f4150c47597be37767d86e | |
| ToppCell | TCGA-Skin-Primary_Tumor-Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 2.50e-05 | 190 | 40 | 4 | 01fb45add4661bc86cd0a34fac35177907152dbb | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibro-meso-mesothelial_cell-Mesothelium-Mesothelium_L.2.6.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.50e-05 | 190 | 40 | 4 | f39ce1678fc375eb2a3af781ddb772b0f12c5744 | |
| ToppCell | TCGA-Skin-Primary_Tumor-Melanoma-Skin_Cutaneous_Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 2.50e-05 | 190 | 40 | 4 | 3188c7bd225cbcf46a21e2fb784336cdd9665995 | |
| ToppCell | LV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 2.55e-05 | 191 | 40 | 4 | d36565257ccba8c1bbed2c1c01be66a9cbb5f834 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Squamous|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.60e-05 | 192 | 40 | 4 | 103496f428f59683ac3ae6147682c07c30663724 | |
| ToppCell | RV-02._Fibroblast_II|RV / Chamber and Cluster_Paper | 2.71e-05 | 194 | 40 | 4 | 11c79a8c56ece42713b04b321982e41e239f07a5 | |
| ToppCell | LV-02._Fibroblast_II|LV / Chamber and Cluster_Paper | 2.71e-05 | 194 | 40 | 4 | 014d2feb5db2a6a35ef759761a41e466e108c3c1 | |
| ToppCell | NS-moderate-d_07-13|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.77e-05 | 195 | 40 | 4 | 088209505a68519ec89f50f0576096da6966bf17 | |
| ToppCell | RV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 2.77e-05 | 195 | 40 | 4 | ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48 | |
| ToppCell | LA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 2.77e-05 | 195 | 40 | 4 | a78b605b49acd8c9d68716266ca269dafcd910b9 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_monocytic|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.82e-05 | 196 | 40 | 4 | 03de28e1c963e99623e8b0e33bf2e8ef67dc3baa | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.88e-05 | 197 | 40 | 4 | fb272c9c60ee3d980e528044dc567b4925a23da6 | |
| ToppCell | critical-Epithelial-Squamous|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.88e-05 | 197 | 40 | 4 | cfbdaada7169afb68455724ae87032ff311b2d89 | |
| ToppCell | NS-control-d_0-4-Epithelial-Squamous|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.88e-05 | 197 | 40 | 4 | ab965a0ba87efd3329d24a1ec123985f46fc17c0 | |
| ToppCell | moderate-Epithelial-Squamous|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.88e-05 | 197 | 40 | 4 | ab3c90a5b643b45d0b83939c6304b11f567c5d78 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_monocytic-leukocyte|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.88e-05 | 197 | 40 | 4 | e621d4f9d4ba5e3ef17d2b477e5e14ea0251147e | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.88e-05 | 197 | 40 | 4 | 61c0d78b29dc4ad8a84172cbfcdab03f31351d0e | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_monocytic|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.88e-05 | 197 | 40 | 4 | 7870c0651caefb0ed13d9f9dab43b5f24d6a9efc | |
| ToppCell | moderate-Epithelial-Squamous|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.88e-05 | 197 | 40 | 4 | 2e13881f917d4f62a5b3e968e41c57e43300d988 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.88e-05 | 197 | 40 | 4 | dcabea5c50c133c9a4e294e447462d0393174ea7 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_monocytic-leukocyte|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.88e-05 | 197 | 40 | 4 | d968d7d5608b175bb567ea3a315bf473ec3be459 | |
| ToppCell | NS-moderate-d_07-13-Epithelial-Squamous|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.94e-05 | 198 | 40 | 4 | b7495369baba203490c067a58fc8456a778a12e4 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.94e-05 | 198 | 40 | 4 | e06d41a7254a09e037ec404be2d8c352d5cbd7f4 | |
| ToppCell | (08)_Brush+PNEC|World / shred by cell type by condition | 3.00e-05 | 199 | 40 | 4 | f2e33cb569c25fc2732722cac295647e9bd8738f | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.00e-05 | 199 | 40 | 4 | 1295f34a350bf48987e2fad411aaac3630efd3f1 | |
| ToppCell | Tracheal-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.05e-05 | 200 | 40 | 4 | 8ab0051544ea32eb8b3f7f8ba7582deaf8bf26c0 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Ductal_and_Metaplastic_Carcinoma|TCGA-Breast / Sample_Type by Project: Shred V9 | 1.83e-04 | 123 | 40 | 3 | 51e49a64fbbf77e2ee21f45fd515d43282b11516 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Ductal_and_Metaplastic_Carcinoma-4|TCGA-Breast / Sample_Type by Project: Shred V9 | 1.83e-04 | 123 | 40 | 3 | 11802979943a9205f10facda322fc220d4bf7133 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Undifferentiated_Pleomorphic_Sarcoma-4|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 2.20e-04 | 131 | 40 | 3 | 2ccf679b5035b7b9cdb9a9a660cad90288592187 | |
| ToppCell | E18.5-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_B|E18.5-samps / Age Group, Lineage, Cell class and subclass | 2.51e-04 | 137 | 40 | 3 | b553958e7e6dcd887d860e34d3983cbb85cefaa6 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma-2|TCGA-Brain / Sample_Type by Project: Shred V9 | 2.62e-04 | 139 | 40 | 3 | 6f6c64eaa1ce84e0aa9a0caa9c4d9bf7afe626df | |
| ToppCell | RV-14._Fibroblast_III|RV / Chamber and Cluster_Paper | 2.68e-04 | 140 | 40 | 3 | b4fee8eb6bf855b364b00bda3f78e49d851bbca0 | |
| ToppCell | 343B-Lymphocytic-CD8+_Cytotoxic_T-cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.03e-04 | 146 | 40 | 3 | bb7bf20245d93c8812920dd0debbf1ed00add378 | |
| ToppCell | Bronchial_Biopsy-Epithelial-Goblet_2|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.47e-04 | 153 | 40 | 3 | b25629953ff79aff645845376132b12023067b01 | |
| ToppCell | Bronchial_Biopsy-Epithelial-Goblet_2|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.47e-04 | 153 | 40 | 3 | e9d6b4e895ddb8d6e6c8b043da591ec11365e124 | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 3.54e-04 | 154 | 40 | 3 | 65dbb60f636562eeba3dafadae9c0c7db2b27476 | |
| ToppCell | PBMC-Control-cDC_1|Control / Compartment, Disease Groups and Clusters | 3.68e-04 | 156 | 40 | 3 | 9b6c5bcac516a62bcc1f5be32ffa8c92735ef0bc | |
| ToppCell | Children_(3_yrs)-Mesenchymal-chondrocyte-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.68e-04 | 156 | 40 | 3 | 60f1ce38e34b582f589db1e0d6139282c1902b2b | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Myofibro_2|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.75e-04 | 157 | 40 | 3 | b9d04ee417c0d8ea0801d10f1c54e138587009fd | |
| ToppCell | frontal_cortex-Non-neuronal-smooth_muscle_cell|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.82e-04 | 158 | 40 | 3 | 08806240228c5b780f5aef92ce2c278ae4d797cc | |
| ToppCell | frontal_cortex-Non-neuronal-smooth_muscle_cell-SMC-SMC_Acta2|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.82e-04 | 158 | 40 | 3 | 496b6988f7b3439968351840ae22f56ffa1643f1 | |
| ToppCell | frontal_cortex-Non-neuronal-smooth_muscle_cell-SMC|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.82e-04 | 158 | 40 | 3 | 5b3d30f92b619f14a7b48502170000fa5783358a | |
| ToppCell | frontal_cortex-Non-neuronal-leptomeningeal_cell-VLMC-VLMC_Spp1_Col15a1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.89e-04 | 159 | 40 | 3 | 34c90711c5857cf6ada7b3acff99f1d48c7caf29 | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 3.89e-04 | 159 | 40 | 3 | 92049a8d8fc9997d8d0d76500c72596a9b2394e0 | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_NOS-4|TCGA-Stomach / Sample_Type by Project: Shred V9 | 4.18e-04 | 163 | 40 | 3 | 6a12b802cb181f979ebc72674f3626fb855024e3 | |
| ToppCell | Adult-Mesenchymal-chondrocyte-D231|Adult / Lineage, Cell type, age group and donor | 4.25e-04 | 164 | 40 | 3 | 2ba57dce5f69a88f0d1e450b9780425e2d9ca7d4 | |
| ToppCell | PND01-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_prolif|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.33e-04 | 165 | 40 | 3 | ba68090d79e2243af2bdee0c27a32e65f540f8ac | |
| ToppCell | BAL-Mild-Myeloid-MoAM-MoAM5-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.41e-04 | 166 | 40 | 3 | 006ced12f69ef13ddcba5a3891ddc7c18c384863 | |
| ToppCell | BAL-Mild-Myeloid-MoAM-MoAM5|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.41e-04 | 166 | 40 | 3 | ac28c8cac1e94be0c47fb862c5809c92cdaa11f3 | |
| ToppCell | BAL-Mild-Myeloid-MoAM-MoAM5-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.41e-04 | 166 | 40 | 3 | 6bb3410e65c971acc458c472015afcec6de6e310 | |
| ToppCell | Control-Epithelial-Mesothelial|Control / Disease state, Lineage and Cell class | 4.41e-04 | 166 | 40 | 3 | 1ed3788257e14f097862b999f020bfe2a57de52b | |
| ToppCell | COPD-Lymphoid-ILC_B|Lymphoid / Disease state, Lineage and Cell class | 4.41e-04 | 166 | 40 | 3 | e2cad1db536d5ad5a34c337c19b5e7d1a2851552 | |
| ToppCell | BAL-Mild-Myeloid-MoAM-MoAM5|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.41e-04 | 166 | 40 | 3 | 823ec03714884cb860a1260410feac8c536b6d06 | |
| ToppCell | Adult-Mesenchymal-myofibroblast_cell|Adult / Lineage, Cell type, age group and donor | 4.49e-04 | 167 | 40 | 3 | d584a8548a5317bd9686b3be8246ae6ed568796b | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_TIP|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 4.56e-04 | 168 | 40 | 3 | 26aa96b2b547d11941cb803995ea3d302ee0518c | |
| ToppCell | frontal_cortex-Non-neuronal-leptomeningeal_cell-VLMC-VLMC_Osr1_Mc5r|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.56e-04 | 168 | 40 | 3 | 9930bd63b60c03f0152838a79eef77da1c2dd8e5 | |
| ToppCell | TCGA-Bile_Duct-Primary_Tumor-Cholangiocarcinoma-Intrahepatic-2|TCGA-Bile_Duct / Sample_Type by Project: Shred V9 | 4.56e-04 | 168 | 40 | 3 | c70bf73bb800e4722cedc35bbc17ea3113d1012d | |
| ToppCell | NS-moderate-d_0-4-Epithelial-Squamous|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.64e-04 | 169 | 40 | 3 | 4a5d023ffcf83312d29b1d215eb6b744ef1a0777 | |
| ToppCell | RA-01._Fibroblast_I|RA / Chamber and Cluster_Paper | 4.64e-04 | 169 | 40 | 3 | 6373562ab3b1765060212a6a53d6543e7e942e80 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.81e-04 | 171 | 40 | 3 | a4a2c5dc995589fbe3d4ca6ee1df888807e4ae34 | |
| ToppCell | 343B-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.89e-04 | 172 | 40 | 3 | d65ffff3e341af34a043a0d802d7ba4b69de36e9 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.89e-04 | 172 | 40 | 3 | 73e9b29b1c6b8b016b495a0d20336d0c0761e5e2 | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 4.97e-04 | 173 | 40 | 3 | 7e3897868dd3f6e4974f593c60649a543ffc8693 | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_D3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 5.06e-04 | 174 | 40 | 3 | e5f12831187140e84b9a49e93b2376b9fefb1aec | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.06e-04 | 174 | 40 | 3 | f90ca117b729436cf452e2ddcec26ba525c5c13b | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_D3|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 5.23e-04 | 176 | 40 | 3 | bd5c85b3a4fb88ffe156599f6d224aa7664a513a | |
| ToppCell | normal_Lung-Fibroblasts-Mesothelial_cells|normal_Lung / Location, Cell class and cell subclass | 5.23e-04 | 176 | 40 | 3 | f31d7234053085a82cf9d55aeedd1e04d34789c3 | |
| ToppCell | 3'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial-LEC3_(ADGRG3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.23e-04 | 176 | 40 | 3 | 5d3b2395bb842eea39175f5af6a4c76527e2fc31 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_1-Mesothelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.31e-04 | 177 | 40 | 3 | 0912a291cff32a4ff8a2d7680ed1a1cd867fb90f | |
| ToppCell | Control-Myeloid-pDC|Myeloid / Disease state, Lineage and Cell class | 5.31e-04 | 177 | 40 | 3 | e82115bfc32c7b689460fbc5caeb983c1aabe30f | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.40e-04 | 178 | 40 | 3 | fcbbcc44271515de1969b4732b6441c012693d5f | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-T_cells-MAIT_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.40e-04 | 178 | 40 | 3 | f52f837e948deb6a2d031325f49891bca8d375da | |
| ToppCell | 15-Airway-Epithelial-Multiciliated_precursor|Airway / Age, Tissue, Lineage and Cell class | 5.40e-04 | 178 | 40 | 3 | d8e0a696bdd6af6422d72af0413f9dbd6bc02afa | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.40e-04 | 178 | 40 | 3 | 73936c2e7e8855b4ab65cad425686513dba331a3 | |
| ToppCell | wk_15-18-Mesenchymal-Mesothelial-intermediate_mesothelial|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 5.49e-04 | 179 | 40 | 3 | b1f085e4c8d65d5cdbfaf2db80343638abb08979 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.49e-04 | 179 | 40 | 3 | 948c2a01ec7a626c68281e6e796a9f0527a88591 | |
| ToppCell | LA-01._Fibroblast_I|LA / Chamber and Cluster_Paper | 5.49e-04 | 179 | 40 | 3 | dcb6ec9ae72b13fe388b72dace2815293fafe8ee | |
| ToppCell | NS|World / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.58e-04 | 180 | 40 | 3 | 8472dcce7bc0b7ce428ec17ddf0018f3258f78d2 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6-Inh_L1_PAX6_CA4|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.58e-04 | 180 | 40 | 3 | 392bc71a69653ba12de31bed4e9357f181094641 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.67e-04 | 181 | 40 | 3 | 8fd64404e57c22c204d835fc5626f73554257b19 | |
| Disease | atrial fibrillation | 7.46e-06 | 371 | 38 | 6 | EFO_0000275 | |
| Disease | mucinous adenocarcinoma (is_marker_for) | 1.61e-05 | 5 | 38 | 2 | DOID:3030 (is_marker_for) | |
| Disease | level of C-X-C motif chemokine 2 in blood serum | 1.06e-04 | 12 | 38 | 2 | OBA_2041207 | |
| Disease | level of C-X-C motif chemokine 3 in blood serum | 1.68e-04 | 15 | 38 | 2 | OBA_2041208 | |
| Disease | lymphocyte measurement | 4.63e-04 | 117 | 38 | 3 | EFO_0803546 | |
| Disease | cardiac arrhythmia | 6.87e-04 | 30 | 38 | 2 | EFO_0004269 | |
| Disease | Paroxysmal atrial fibrillation | 1.07e-03 | 156 | 38 | 3 | C0235480 | |
| Disease | Persistent atrial fibrillation | 1.07e-03 | 156 | 38 | 3 | C2585653 | |
| Disease | familial atrial fibrillation | 1.07e-03 | 156 | 38 | 3 | C3468561 | |
| Disease | Atrial Fibrillation | 1.15e-03 | 160 | 38 | 3 | C0004238 | |
| Disease | liver fat measurement | 1.41e-03 | 43 | 38 | 2 | EFO_0010821 | |
| Disease | esophagus squamous cell carcinoma (is_implicated_in) | 1.54e-03 | 45 | 38 | 2 | DOID:3748 (is_implicated_in) | |
| Disease | Salivary Gland Neoplasms | 1.68e-03 | 47 | 38 | 2 | C0036095 | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 2.14e-03 | 53 | 38 | 2 | C4707243 | |
| Disease | Cerebrovascular accident | 2.91e-03 | 62 | 38 | 2 | C0038454 | |
| Disease | diabetes mellitus | 3.49e-03 | 68 | 38 | 2 | EFO_0000400 | |
| Disease | PR interval | 3.68e-03 | 495 | 38 | 4 | EFO_0004462 | |
| Disease | autoimmune thyroid disease, systemic lupus erythematosus, type 1 diabetes mellitus, ankylosing spondylitis, psoriasis, common variable immunodeficiency, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis | 3.69e-03 | 70 | 38 | 2 | EFO_0000384, EFO_0000676, EFO_0000729, EFO_0001060, EFO_0002609, EFO_0003898, EFO_0005140, EFO_0006812, MONDO_0005147, MONDO_0007915, MONDO_0015517 | |
| Disease | allergic disease, age at onset | 3.79e-03 | 71 | 38 | 2 | EFO_0004847, MONDO_0005271 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RRPPAPQQPPKPCDS | 1321 | O00468 | |
| APQIPPPNNARAPSP | 1081 | Q68CP9 | |
| TSPPRQPCTSPPRQP | 671 | Q569K6 | |
| PPRQPCTSPPRQPCT | 681 | Q569K6 | |
| VCSVAPNLPPPPPSN | 4301 | Q14517 | |
| PSQLPPTSCSQNPQP | 401 | A5PL33 | |
| CTLFPPNPNLPPPAT | 106 | Q16206 | |
| PPPASPQQPRRCSPF | 61 | Q13370 | |
| PSGLQPPNCLQPCTP | 166 | Q5VY43 | |
| SQCSPNPPPPNKVPG | 826 | Q5VY43 | |
| PPPPQLANSTSCDPP | 386 | Q9BTN0 | |
| CRFCPPPPPPYQNQS | 5516 | P98088 | |
| PPPPTPPGTLVQCQQ | 1081 | Q9UPP2 | |
| PPPQQPPQPASASCE | 166 | Q9Y3Q4 | |
| QNTGPSPSPNPCSNP | 721 | Q8IZL2 | |
| QQPPPPPRTEAAPAA | 31 | Q6P988 | |
| RAQPPAASPQPCPAP | 16 | Q6U949 | |
| QPPPQPTQPSAQARC | 111 | A0A1B0GVQ3 | |
| PPPAAPQQPQSRRSP | 76 | Q7Z5Q1 | |
| PASQPSQPQPPRPAA | 111 | Q9NQL9 | |
| PLAPATPTPSQQCPQ | 121 | Q674R7 | |
| SSPVCVPPENPPQPQ | 226 | P42701 | |
| PPNVPKCSPPQRSNP | 11 | A0A183 | |
| QGRPCPPPQAPANQP | 756 | Q76NI1 | |
| AVCPQPPTAPTRPPN | 86 | P02461 | |
| ASRTPTPQNPPNPPS | 2131 | Q58EX2 | |
| ATKNRPCQPPPPPTL | 41 | Q8N461 | |
| PQFPLPPGAQQCPPV | 146 | Q96NZ1 | |
| PPPTCRQLSPNPAPD | 171 | Q6BEB4 | |
| PPQPPQPSCSPCAPR | 141 | Q9HB58 | |
| PVQSTQPAQPAPPCP | 3356 | Q96T58 | |
| QPAQPAPPCPPSQLG | 3361 | Q96T58 | |
| QQKYPPVTPSPPCQP | 51 | P35325 | |
| QQKYPPVTPSPPCQP | 51 | P22532 | |
| QQKCPPVTPSPPCQP | 51 | P22531 | |
| QQKCPPVTPSPPCQP | 51 | Q96RM1 | |
| SCTPPQSPQPDPRPL | 101 | Q8N9P0 | |
| PPPQPQVCPTPSQGA | 141 | Q6ZS46 | |
| AAPPCPPCQSPVPQR | 356 | A7MCY6 | |
| PPCQSPVPQRRSPVP | 361 | A7MCY6 | |
| PQRRSPVPPSCPAPQ | 411 | A7MCY6 | |
| PSQPPRQPPQAAPSS | 986 | Q9ULJ6 | |
| QAPPPQCPLPQSSPS | 2486 | Q15911 | |
| PGTPSQNTQCQPCPP | 141 | O95407 | |
| SCPQPPPAPQPQARS | 11 | O76024 | |
| QILPPCQVPPPSGPQ | 1321 | O15069 | |
| PPPCSPAPQQCPLSA | 46 | E9PAV3 |